Evidence map›Paper›PMID 33363954›Full record

ArticleClinical case reports2020

Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti-androgen therapy-A case report.

Fanny Collette, Marc Hamoir, Pascal Van Eeckhout, Philippe D'Abadie, Thierry Duprez, Sandra Schmitz, Jean-Pascal Machiels

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fanny ColletteInstitut Roi Albert II Department of Medical Oncology Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (POLE MIRO) Université catholique de Louvain Brussels Belgium.ORCID https://orcid.org/0000-0002-5825-3209
Marc HamoirInstitut Roi Albert II Department of Head and Neck Surgery Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (POLE MIRO) Université catholique de Louvain Brussels Belgium.
Pascal Van EeckhoutInstitut Roi Albert II Department of Pathology Cliniques universitaires Saint-Luc Brussels Belgium.
Philippe D'AbadieInstitut Roi Albert II Department of Nuclear Medicine Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (POLE MIRO) Université catholique de Louvain Brussels Belgium.
Thierry DuprezInstitut Roi Albert II Department of Medical Imaging Cliniques universitaires Saint-Luc Brussels Belgium.
Sandra SchmitzInstitut Roi Albert II Department of Head and Neck Surgery Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (POLE MIRO) Université catholique de Louvain Brussels Belgium.
Jean-Pascal MachielsInstitut Roi Albert II Department of Medical Oncology Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (POLE MIRO) Université catholique de Louvain Brussels Belgium.
Cliniques Universitaires Saint-Luc · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary cutaneous apocrine adenocarcinoma (PCAC) is an extremely rare neoplasm involving the sweat glands. Due to a lack of cases, there is no consensus for the systemic treatment of locally advanced or metastatic PCAC. Anti-androgen therapy may have activity in inoperable or metastatic PCAC with high androgen receptor (AR) expression.

Indexed as

androgen receptoranti‐androgen therapymetastatic cancerPrimary cutaneous apocrine adenocarcinomasweat glands

Identifiers

PMID33363954
PMCPMC7752452
OpenAlexW3096608945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.